The largest insider transaction on today’s list comes in a Form 4 filed by Sylebra Capital Ltd, which revealed an additional purchase of $5.2 million in Impinj Inc $PI.
Patrick J. Heron, director of Mirum Pharmaceuticals $MIRM, revealed a purchase of 147,991 shares, equivalent to $3,884,763.
The largest insider transaction on today’s list comes in a Form 4 filed by Sylebra Capital Ltd, which revealed a purchase of $8 million in Impinj Inc $PI.
The hedge fund now owns 3,869,196 shares, representing an ownership stake of roughly 14%.